Login to Your Account



Prometic Secures $10M for GMP Facility

By Catherine Shaffer
Staff Writer

Wednesday, September 11, 2013

Prometic Life Sciences Inc., of Laval, Quebec, will earmark a portion of the proceeds from a $10 million financing from Thomvest Seed Capital Inc. to commission its GMP facility for manufacture of plasma-derived orphan drugs. The financing will take the form of a long-term loan secured by Prometic’s assets, except for its patent portfolio.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription